Expression and prognostic value of C-reactive protein in adult immune thrombocytopenia (ITP) patients.

[1]  C. Greineder,et al.  Anchoring IgG-degrading enzymes to the surface of platelets selectively neutralizes antiplatelet antibodies , 2022, Blood advances.

[2]  H. Yhim,et al.  Sequential eradication of Helicobacter pylori as a treatment for immune thrombocytopenia in patients with moderate thrombocytopenia: a multicenter prospective randomized phase 3 study , 2022, Annals of Hematology.

[3]  L. de Chaisemartin,et al.  The role of neutrophils in antibody-driven autoimmune cytopenias. , 2022, The international journal of biochemistry & cell biology.

[4]  C. Lu,et al.  Comparison of antiplatelet antibody profiles between hepatitis C virus-associated immune thrombocytopenia and primary immune thrombocytopenia , 2020, Platelets.

[5]  M. Anvari,et al.  Diagnostic Value of C-Reactive Protein Levels in Postoperative Infectious Complications After Bariatric Surgery: a Systematic Review and Meta-Analysis , 2019, Obesity Surgery.

[6]  M. B. Bacchi Reggiani,et al.  Understanding how older age drives decision‐making and outcome in Immune Thrombocytopenia. A single centre study on 465 adult patients , 2018, British journal of haematology.

[7]  J. Medina,et al.  Risk classification in primary prevention of CVD according to QRISK2 and JBS3 ‘heart age’, and prevalence of elevated high-sensitivity C reactive protein in the UK cohort of the EURIKA study , 2018, Open Heart.

[8]  J. Ashworth,et al.  Role of C-Reactive Protein at Sites of Inflammation and Infection , 2018, Front. Immunol..

[9]  J. Semple.  C-reactive protein boosts antibody-mediated platelet destruction. , 2015, Blood.

[10]  R. Schasfoort,et al.  C-reactive protein enhances IgG-mediated phagocyte responses and thrombocytopenia. , 2015, Blood.

[11]  S. Steinhubl,et al.  Bleeding events are associated with an increase in markers of inflammation in acute coronary syndromes: an ACUITY trial substudy , 2011, Journal of Thrombosis and Thrombolysis.

[12]  W. Borkowsky,et al.  Role of molecular mimicry of hepatitis C virus protein with platelet GPIIIa in hepatitis C-related immunologic thrombocytopenia. , 2008, Blood.

[13]  S. Karpatkin,et al.  Role of molecular mimicry to HIV-1 peptides in HIV-1-related immunologic thrombocytopenia. , 2005, Blood.

[14]  P. Ridker,et al.  Inflammatory bio‐markers and cardiovascular risk prediction , 2002, Journal of internal medicine.

[15]  J. Freedman,et al.  Characterization of platelet‐reactive antibodies in children with varicella‐associated acute immune thrombocytopenic purpura (ITP) , 1996, British journal of haematology.

[16]  P. Tani,et al.  Complement activation in vitro by antiplatelet antibodies in chronic immune thrombocytopenic purpura , 1986, British journal of haematology.